Chemistry:3C-AL

From HandWiki

3C-AL, also known as 4-allyloxy-3,5-dimethoxyamphetamine or as α-methylallylescaline (3C-allylescaline), is a psychedelic drug of the phenethylamine, amphetamine, and 3C families related to 3,4,5-trimethoxyamphetamine (TMA).[1][2][3] It is the amphetamine (3C) analogue of allylescaline.[1][2][3] The drug has a dose range of 15 to 30 mg orally and a duration of 8 to 12 hours.[2][3] Its effects have been described as more visual than those of allylescaline.[2] The drug is a potent partial agonist of the serotonin 5-HT2A receptor and also interacts with other serotonin receptors and targets.[3] The chemical synthesis of 3C-AL has been described.[1][4] 3C-AL was described by Alexander Shulgin in his 1991 book PiHKAL (Phenethylamines I Have Known and Loved), but he did not synthesize or test 3C-AL.[1] Instead, Daniel Trachsel synthesized 3C-AL in 2002[4] and described its properties and effects in 2013.[2] The pharmacology of 3C-AL was studied in greater detail in 2021.[3]

See also

References

  1. 1.0 1.1 1.2 1.3 "AL". PiHKAL. http://www.erowid.org/library/books_online/pihkal/pihkal002.shtml. 
  2. 2.0 2.1 2.2 2.3 2.4 (in de) Phenethylamine: von der Struktur zur Funktion. Nachtschatten-Science (1 ed.). Solothurn: Nachtschatten-Verlag. 2013. pp. 642–643, 736–737. ISBN 978-3-03788-700-4. OCLC 858805226. https://books.google.com/books?id=-Us1kgEACAAJ. Retrieved 31 January 2025. 
  3. 3.0 3.1 3.2 3.3 3.4 "Receptor Interaction Profiles of 4-Alkoxy-3,5-Dimethoxy-Phenethylamines (Mescaline Derivatives) and Related Amphetamines". Front Pharmacol 12. 2021. doi:10.3389/fphar.2021.794254. PMID 35222010. 
  4. 4.0 4.1 "Synthesis of novel (phenylalkyl)amines for the investigation of structure-activity relationships. Part 1. Mescalin derivatives.". Helvetica Chimica Acta 85 (9): 3019–3026. 2002. doi:10.1002/1522-2675(200209)85:9<3019::AID-HLCA3019>3.0.CO;2-4. 

Template:Psychedelics

Template:TAAR modulators